ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Outpatient Treatment With Anti-Coronavirus Immunoglobulin

ClinicalTrials.gov ID: NCT04910269

Public ClinicalTrials.gov record NCT04910269. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 4:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An International Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the Treatment of Adult Outpatients in Early Stages of COVID-19

Study identification

NCT ID
NCT04910269
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
University of Minnesota
Other
Enrollment
820 participants

Conditions and interventions

Interventions

  • Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG) Biological
  • Placebo Other

Biological · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 5, 2021
Primary completion
Jul 31, 2026
Completion
Jul 31, 2026
Last update posted
Apr 19, 2026

2021 – 2026

United States locations

U.S. sites
22
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Southern Arizona VA Healthcare System (074-009) Tucson Arizona 85723 Terminated
VA Northern California Health Care System (074-023) Mather California 95655 Terminated
Stanford University Hospital & Clinics (Site 203-003) Palo Alto California 94305 Recruiting
San Francisco VAMC (Site 074-002) San Francisco California 94121 Terminated
Rocky Mountain Regional VA Medical Center (074-010) Aurora Colorado 80045 Terminated
MedStar Health Research Institute Washington D.C. District of Columbia 20010 Withdrawn
Washington DC Veterans Affairs Medical Center Washington D.C. District of Columbia 20422 Withdrawn
University of Maryland Medical System Baltimore Maryland 21201 Withdrawn
Henry Ford Health System Site (014-001) Detroit Michigan 48202 Recruiting
Infusion Associates Grand Rapids Michigan 49525 Withdrawn
Mount Sinai Beth Israel Hospital New York New York 10003 Withdrawn
Icahn School of Medicine at Mount Sinai New York New York 10029 Terminated
Cleveland Clinic Foundation (Site 207-001) Cleveland Ohio 44195 Recruiting
Penn State Health Milton S. Hershey Medical Center (209-002) Hershey Pennsylvania 17033 Recruiting
Hendrick Medical Center Abilene Texas 79601 Withdrawn
CHRISTUS Spohn Shoreline Hospital Corpus Christi Texas 78404 Recruiting
UT Southwestern Medical Center Dallas Texas 75390 Recruiting
Intermountain Medical Center (211-001) Murray Utah 84107 Recruiting
UVA Health System, University Hospital (Site 210-003) Charlottesville Virginia 22908 Recruiting
Carilion Medical Center (Site 080-018) Roanoke Virginia 24015 Recruiting
Salem VA Medical Center (074-014) Salem Virginia 24153 Terminated
Swedish Hospital First Hill Seattle Washington 98122 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04910269, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 19, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04910269 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →